Healthy financing opportunities.

LDC has invested more than £280million of equity capital to back more than 35 businesses across the healthcare industry over the last 35 years.

The UK healthcare and pharmaceuticals sector is thriving. Fundamental growth drivers, including an ageing population, increasing influence of technology and demand for homecare has created significant opportunity.

Our team has built an enviable track record in backing the growth ambitions of management teams from across the sector, with particular experience in the dynamic pharmaceutical, medical communications and medical equipment industries.

Having worked with management teams from Fishawack and ChargePoint Technology to Synexus, Prism Medical and Quantum Pharmaceutical to support their growth plans, LDC remains an active investor in the healthcare sector.

Recent Healthcare Transactions

  • The Duncan & Todd Group Logo

    The Duncan & Todd Group

    The Duncan & Todd Group is the leading optical provider in Scotland.
    Sector
    Retail & Consumer
    Deal Type
    Secondary Buyout
    Deal Size
    Less than £20m
    Entry Date
    21/03/2018
  • Lucid Group Logo

    Lucid Group

    Lucid Group Communications is a specialist provider of strategic medical communications services to global pharmaceutical companies. 
    Sector
    Healthcare
    Deal Type
    Development Capital
    Deal Size
    Less than £20m
    Entry Date
    12/06/2017